After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'
By Jeff Overley and Eric Heisig · November 2, 2022, 11:35 PM EDT
Multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login